Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fibronectin Antibody [SPM539] | Login | Fibronectin Antibody [SPM539] | ||||||||||||||||
|
||||||||||||||||||
| Fibronectin Antibody [SPM246] | Login | Fibronectin Antibody [SPM246] | ||||||||||||||||
|
||||||||||||||||||
| Glial Fibrillary Acidic Protein Antibody [SPM248] | Login | Glial Fibrillary Acidic Protein Antibody [SPM248] | ||||||||||||||||
|
||||||||||||||||||
| GFAP Antibody [SPM507] | Login | GFAP Antibody [SPM507] | ||||||||||||||||
|
||||||||||||||||||
| Kappa Light Chain Antibody [SPM508] | Login | Kappa Light Chain Antibody [SPM508] | ||||||||||||||||
|
||||||||||||||||||
| Kappa Antibody [SPM558] | Login | Kappa Antibody [SPM558] | ||||||||||||||||
|
||||||||||||||||||
| Lambda Antibody [SPM559] | Login | Lambda Antibody [SPM559] | ||||||||||||||||
|
||||||||||||||||||
| PSA Antibody [SPM352] | Login | PSA Antibody [SPM352] | ||||||||||||||||
|
||||||||||||||||||
| Insulin Antibody [SPM139] | Login | Insulin Antibody [SPM139] | ||||||||||||||||
|
||||||||||||||||||
| Involucrin Antibody [SPM259] | Login | Involucrin Antibody [SPM259] | ||||||||||||||||
|
||||||||||||||||||
| Cytokeratin 8 Antibody [SPM538] | Login | Cytokeratin 8 Antibody [SPM538] | ||||||||||||||||
|
||||||||||||||||||
| Cytokeratin 8 Antibody [SPM192] | Login | Cytokeratin 8 Antibody [SPM192] | ||||||||||||||||
|
||||||||||||||||||
| EpCAM Antibody [SPM528] | Login | EpCAM Antibody [SPM528] | ||||||||||||||||
|
||||||||||||||||||
| MUC1 Antibody [SPM132] | Login | MUC1 Antibody [SPM132] | ||||||||||||||||
|
||||||||||||||||||
| Mucin-1 Antibody [SPM533] | Login | Mucin-1 Antibody [SPM533] | ||||||||||||||||
|
||||||||||||||||||
| MUC2 Antibody [SPM296] | Login | MUC2 Antibody [SPM296] | ||||||||||||||||
|
||||||||||||||||||
| Mucin-2 Antibody [SPM513] | Login | Mucin-2 Antibody [SPM513] | ||||||||||||||||
|
||||||||||||||||||
| Mucin-5AC Antibody [SPM297] | Login | Mucin-5AC Antibody [SPM297] | ||||||||||||||||
|
||||||||||||||||||
| MyoD1 Antibody [SPM427] | Login | MyoD1 Antibody [SPM427] | ||||||||||||||||
|
||||||||||||||||||
| Myogenin Antibody [SPM144] | Login | Myogenin Antibody [SPM144] | ||||||||||||||||
|
||||||||||||||||||
| CD56 Antibody [SPM128] | Login | CD56 Antibody [SPM128] | ||||||||||||||||
|
||||||||||||||||||
| CD56 Antibody [SPM489] | Login | CD56 Antibody [SPM489] | ||||||||||||||||
|
||||||||||||||||||
| Neurofilament Antibody [SPM563] | Login | Neurofilament Antibody [SPM563] | ||||||||||||||||
|
||||||||||||||||||
| Cytokeratin 10 Antibody [SPM261] | Login | Cytokeratin 10 Antibody [SPM261] | ||||||||||||||||
|
||||||||||||||||||
| Cytokeratin 14 Antibody [SPM263] | Login | Cytokeratin 14 Antibody [SPM263] | ||||||||||||||||
|
||||||||||||||||||


